Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japan Lung Cancer Society-Reference-Cited by-同舟云学术

Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japan Lung Cancer Society

Published:2023-06-20 Issue:3 Volume:63 Page:161-181
ISSN:0386-9628
Container-title:Haigan
language:en
Short-container-title:JJLC

Author:

Ozawa Yuichi¹,Yamamoto Nobuyuki²,Yamamoto Kouji³,Ito Kentaro⁴,Kenmotsu Hirotsugu⁵,Hayashi Hidetoshi⁶,Shukuya Takehito⁷,Fujimoto Daichi²,Sugawara Shunichi⁸,Niho Seiji⁹,Ohe Yuichiro¹⁰,Okamoto Hiroaki¹¹,Nakagawa Kazuhiko⁶,Kiura Katsuyuki¹²,Yoshino Ichiro¹³,Gemma Akihiko¹⁴

Affiliation:

1. Department of Respiratory Medicine, Hamamatsu Medical Center

2. Internal Medicine III, Wakayama Medical University

3. Department of Biostatistics, Yokohama City University Graduate School of Medicine

4. Respiratory Center, Matsusaka Municipal Hospital

5. Division of Thoracic Oncology, Shizuoka Cancer Center

6. Department of Medical Oncology, Kindai University Faculty of Medicine

7. Department of Respiratory Medicine, Juntendo University Graduate School of Medicine

8. Department of Pulmonary Medicine, Sendai Kousei Hospital

9. Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine

10. Department of Thoracic Oncology, National Cancer Center Hospital

11. Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital

12. Department of Allergy and Respiratory Medicine, Okayama University Hospital

13. Department of General Thoracic Surgery, Chiba University Graduate School of Medicine

14. Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School

Publisher

Japan Lung Cancer Society

Subject

Pulmonary and Respiratory Medicine,Oncology

Link

https://www.jstage.jst.go.jp/article/haigan/63/3/63_161/_pdf

Reference34 articles.

1. 1. Mello MM, Lieou V, Goodman SN. Clinical trial participants' views of the risks and benefits of data sharing. N Engl J Med. 2018; 378: 2202-2211.

2. 2. Baronikova S, Purvis J, Southam E, Beeso J, Panayi A, Winchester C. Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment. BMJ Evid Based Med. 2019; 24: 177-184.

3. 3. Atagi S, Kawahara M, Tamura T, Noda K, Watanabe K, Yokoyama A, et al. Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812). Jpn J Clin Oncol. 2005; 35: 195-201.

4. 4. Atagi S, Kawahara M, Yokoyama A, Okamoto H, Yamamoto N, Ohe Y, et al. Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). Lancet Oncol. 2012; 13: 671-678.

5. 5. Atagi S, Mizusawa J, Ishikura S, Takahashi T, Okamoto H, Tanaka H, et al. Chemoradiotherapy in elderly patients with non-small-cell lung cancer: long-term follow-up of a randomized trial (JCOG0301). Clin Lung Cancer. 2018; 19: e619-e627.